Search - tctmd.com

Displaying 541 - 560 of 610

Sort: Relevancy | Date

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Industry News

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

October 07, 2015

News Opinion Fellow Talk

The Faith of ‘Investing’ in Chronic Total Occlusion Interventions

Henry Quevedo, MD

September 22, 2015

News Daily News

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

August 25, 2015

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Industry News

Sorin Group Announces European Launch of REPLY CRT-P, the World’s Smallest Cardiac Resynchronization Pacemaker

July 31, 2015

News Industry News

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

July 27, 2015

News Opinion Fellow Talk

5 Tips for Successfully Matching With an Interventional Cardiology Fellowship Program

Sarah Elsayed, MD

July 13, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Daily News

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

Todd Neale

June 25, 2015

News Daily News

导管传送基因疗法在晚期心力衰竭患者中表现出积极的迹象

June 23, 2015

News Daily News

Una Terapia Génica administrada por Catéter es Positiva en el Manejo de la Insuficiencia Cardíaca Avanzada

June 23, 2015

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Featured Fellow

Jesse Naghi, MD

Yael L. Maxwell

June 11, 2015

News Daily News

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

L.A. McKeown

February 19, 2015

News Daily News

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Yael L. Maxwell

October 24, 2014

News Industry News

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

October 13, 2014

News Industry News

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

September 17, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

Advertisement

Global TAVR Market Poised to Exceed DES Market by 2025

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

The Faith of ‘Investing’ in Chronic Total Occlusion Interventions

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Sorin Group Announces European Launch of REPLY CRT-P, the World’s Smallest Cardiac Resynchronization Pacemaker

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

5 Tips for Successfully Matching With an Interventional Cardiology Fellowship Program

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

导管传送基因疗法在晚期心力衰竭患者中表现出积极的迹象

Una Terapia Génica administrada por Catéter es Positiva en el Manejo de la Insuficiencia Cardíaca Avanzada

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Jesse Naghi, MD

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content